Swiss medtech is transitioning into the next era of innovation, building on traditional strengths in whole supply chain, discovery, commercial, R&D, production and clinical trials. So says Switzerland Global Enterprise (SGE) director of investment promotion Sirpa Tsimal. “A lot of companies set up a regional headquarters, not just for the Swiss market but also as a hub for Europe or EMEA,” she said.
Medtronic plc is the biggest and probably the most visible example, having moved from Brussels, Belgium to set up...